Back
MoonLake Immunotherapeutics Stock Price Chart
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.
Buy
56
MLTX
MoonLake Immunotherapeutics
Last Price:
51.59
Seasonality Move:
15.96%
7 Day Trial
ALL ACCESS PASS
$
7
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.- The current trend is moderately bullish and MLTX is experiencing selling pressure, which indicates risk of future bearish movement.
MoonLake Immunotherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.58 | Buy |
| 20-day SMA: | 48.78 | Buy |
| 50-day SMA: | 49.67 | Buy |
| 200-day SMA: | 47.13 | Buy |
| 8-day EMA: | 50.77 | Buy |
| 20-day EMA: | 49.69 | Buy |
| 50-day EMA: | 49.01 | Buy |
| 200-day EMA: | 47.08 | Buy |
MoonLake Immunotherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.67 | Buy |
| Relative Strength Index (14 RSI): | 54.96 | Buy |
| Chaikin Money Flow: | -105238 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (46.65 - 50.67) | Buy |
| Bollinger Bands (100): | (43.69 - 50.95) | Buy |
MoonLake Immunotherapeutics Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for MoonLake Immunotherapeutics Stock
Is MoonLake Immunotherapeutics Stock a Buy?
- MoonLake Immunotherapeutics share price is 51.06 while MLTX 8-day simple moving average is 50.58, which is a Buy signal.
- The stock price of MLTX is 51.06 while MoonLake Immunotherapeutics 20-day SMA is 48.78, which makes it a Buy.
- MoonLake Immunotherapeutics 50-day simple moving average is 49.67 while MLTX share price is 51.06, making it a Buy technically.
- MLTX stock price is 51.06 and MoonLake Immunotherapeutics 200-day simple moving average is 47.13, creating a Buy signal.
MLTX Technical Analysis vs Fundamental Analysis
Buy
56
MoonLake Immunotherapeutics (MLTX)
is a Buy
Is MoonLake Immunotherapeutics a Buy or a Sell?
-
MoonLake Immunotherapeutics stock is rated a Buy
The current MoonLake Immunotherapeutics [MLTX] share price is $51.06. The Score for MLTX is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
MoonLake Immunotherapeutics Stock Info
Market Cap:
3.21B
Price in USD:
51.06
Share Volume:
119.55K
MoonLake Immunotherapeutics 52-Week Range
52-Week High:
64.98
52-Week Low:
35.78
Buy
56
MoonLake Immunotherapeutics (MLTX)
is a Buy
MoonLake Immunotherapeutics Share Price Forecast
-
What is the MoonLake Immunotherapeutics stock price today?
The MoonLake Immunotherapeutics stock price is 51.06 USD today. -
Will MLTX stock go up or go down?
MoonLake Immunotherapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is MoonLake Immunotherapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, MoonLake Immunotherapeutics is not overvalued.
Is MoonLake Immunotherapeutics Stock a Buy?
- MoonLake Immunotherapeutics share price is 51.06 while MLTX 8-day exponential moving average is 50.77, which is a Buy signal.
- The stock price of MLTX is 51.06 while MoonLake Immunotherapeutics 20-day EMA is 49.69, which makes it a Buy.
- MoonLake Immunotherapeutics 50-day exponential moving average is 49.01 while MLTX share price is 51.06, making it a Buy technically.
- MLTX stock price is 51.06 and MoonLake Immunotherapeutics 200-day simple moving average is 47.08, creating a Buy signal.
Fundamental Analysis of MoonLake Immunotherapeutics
Is MoonLake Immunotherapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.30 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.87 per share, and a decrease next year of $0.72 per share.
Technical Analysis of MoonLake Immunotherapeutics
Should I short MoonLake Immunotherapeutics stock?
- MLTX Moving Average Covergence Divergence (MACD) indicator is 0.67, suggesting MoonLake Immunotherapeutics is a Buy
- MoonLake Immunotherapeutics Relative Strength Index (RSI) is 54.96, which suggest MoonLake Immunotherapeutics is overbought
- The Bollinger Bands (25) for MoonLake Immunotherapeutics is (46.65 - 50.67), which suggest MoonLake Immunotherapeutics is a Buy
- The Bollinger Bands (100) for MoonLake Immunotherapeutics is (43.69 - 50.95), which suggest MoonLake Immunotherapeutics is a Buy
* MoonLake Immunotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.